AI-driven pricing is transforming the way businesses set and adjust prices in real time. But how do you know if your company is ready to leverage AI for pricing optimization? In this webinar, we’ll break down the different types of AI-powered pricing strategies, where they work best, and how they can drive revenue and margin improvements. 

Key takeaways include:

• Identifying the right AI approach for your industry and business goals
• Assessing if your data is ‘AI-ready’ for effective pricing optimization
• Practical steps to implement AI pricing for maximum impact 

Whether you're new to AI-based pricing or looking to refine your strategy, this session will equip you with the knowledge to make informed decisions and drive success. 

AI is fundamentally changing the way how pricing is done: Instead of ex-post analyses and cumbersome discussions on price architecture, price models and price points, AI brings full rigor to improve pricing decision plus on top can fully automate the pricing process. Some frontrunning companies have understood this already and started early on to make sense of their transactional, customer or market data for more elaborated pricing.

In this webinar, we dive into the state of AI powered pricing by looking into the key insights from Horváth’s 3rd global AI powered Pricing Survey and focus particularly on what firm can learn from AI pricing champions that have leveraged AI already substantially and achieve above average returns. Last but not least, we inspire you with 4 hands-on demos on (Gen)AI use cases in pricing and sales to get stated quickly.

As drug prices and the cost of care continue to rise worldwide, it’s more important than ever to bring therapies to patients in a cost-effective way. We believe that innovative reimbursement agreements will continue to provide a vital gateway to patient access in coming years. This year we monitored publicly available agreements across the US, Europe and many emerging markets.  

Hear from Industry expert, Daniel Parle, as he shares findings and insights from the 2024 Report. We’ll discuss this year’s data from Lyfegen’s public access agreements Library, which reflects a significant shift toward innovative reimbursement agreements that support the accessibility of high-cost therapies. We will also share how data and AI can help to improve drug contract negotiations and enable accelerated access. 

The landscape of pricing teams is evolving rapidly, driven by technological advancements, market dynamics, and changing customer behaviors. We will delve into these transformations, share insights, and explore forward-looking strategies that can shape the success of businesses. You will learn: 

• The role of AI and technology in pricing 

• Setting a team size for pricing teams 

• Future skills for pricing professionals